Your browser doesn't support javascript.
loading
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman, Nigel; Abdulla, Ahmed; Bagust, Adrian; Beale, Sophie; Richardson, Marty; Stainthorpe, Angela; Boland, Angela; Kotas, Eleanor; McEntee, Joanne; Palmer, Daniel.
Affiliation
  • Fleeman N; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK. nigel.fleeman@liverpool.ac.uk.
  • Abdulla A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Bagust A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Beale S; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Richardson M; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Stainthorpe A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Boland A; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • Kotas E; Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, L69 3GB, UK.
  • McEntee J; North West Medicines Information Centre, Liverpool, L69 3GF, UK.
  • Palmer D; Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK.
Pharmacoeconomics ; 36(3): 289-299, 2018 03.
Article in En | MEDLINE | ID: mdl-29178025

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Technology Assessment, Biomedical / Cost-Benefit Analysis / Irinotecan Type of study: Clinical_trials / Guideline / Health_technology_assessment / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Technology Assessment, Biomedical / Cost-Benefit Analysis / Irinotecan Type of study: Clinical_trials / Guideline / Health_technology_assessment / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: New Zealand